1. Home
  2. VSH vs ANIP Comparison

VSH vs ANIP Comparison

Compare VSH & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • ANIP
  • Stock Information
  • Founded
  • VSH 1962
  • ANIP 2001
  • Country
  • VSH United States
  • ANIP United States
  • Employees
  • VSH N/A
  • ANIP N/A
  • Industry
  • VSH Electrical Products
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSH Technology
  • ANIP Health Care
  • Exchange
  • VSH Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • VSH 2.3B
  • ANIP 2.0B
  • IPO Year
  • VSH N/A
  • ANIP N/A
  • Fundamental
  • Price
  • VSH $15.32
  • ANIP $92.62
  • Analyst Decision
  • VSH Hold
  • ANIP Strong Buy
  • Analyst Count
  • VSH 1
  • ANIP 7
  • Target Price
  • VSH $19.00
  • ANIP $99.14
  • AVG Volume (30 Days)
  • VSH 1.9M
  • ANIP 326.2K
  • Earning Date
  • VSH 11-05-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • VSH 2.61%
  • ANIP N/A
  • EPS Growth
  • VSH N/A
  • ANIP N/A
  • EPS
  • VSH N/A
  • ANIP N/A
  • Revenue
  • VSH $2,982,842,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • VSH $4.58
  • ANIP $40.23
  • Revenue Next Year
  • VSH $7.19
  • ANIP $9.65
  • P/E Ratio
  • VSH N/A
  • ANIP N/A
  • Revenue Growth
  • VSH N/A
  • ANIP 38.68
  • 52 Week Low
  • VSH $10.35
  • ANIP $52.50
  • 52 Week High
  • VSH $20.15
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • VSH 40.31
  • ANIP 50.00
  • Support Level
  • VSH $16.64
  • ANIP $89.47
  • Resistance Level
  • VSH $17.27
  • ANIP $93.80
  • Average True Range (ATR)
  • VSH 0.68
  • ANIP 3.23
  • MACD
  • VSH -0.18
  • ANIP -0.03
  • Stochastic Oscillator
  • VSH 20.06
  • ANIP 41.92

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: